Understanding Genitourinary Syndrome of Menopause: Why Vaginal Estrogen Matters
Written and edited by Sarah Bonza MD, MPH, FAAFP, MSCP, DipABLM, NBC-HWC
Understanding and managing genitourinary syndrome of menopause and perimenopause
Menopause often brings to mind hot flashes, night sweats, and shifting moods. However, there is another concern that doesn’t always receive enough attention: Genitourinary Syndrome of Menopause (GSM). According to The Menopause Society (www.menopause.org), GSM refers to a wide group of symptoms including vaginal dryness, burning, and irritation, as well as urinary problems such as frequent infections or urgency. These changes can have a considerable impact on quality of life, but there is hope. Vaginal estrogen therapy has shown strong benefits in relieving symptoms and helping women feel more like themselves again.
What is Genitourinary Syndrome of Menopause?
GSM describes a range of symptoms related to declining estrogen levels that occur during the menopausal transition and beyond. When ovarian function decreases, the body produces less estrogen, and the tissues of the vagina and lower urinary tract are especially sensitive to this shift. Without enough estrogen, these tissues can become thin, less elastic, and more fragile. The result may include:
Vaginal dryness
Burning and itching in the vaginal area
Discomfort or pain during intimacy
Increased frequency of urinary tract infections (UTIs)
Urinary urgency or a feeling of incomplete emptying
For a long time, people called these problems “vaginal atrophy.” In 2014, leading experts created the term Genitourinary Syndrome of Menopause to bring wider recognition to the broad combination of vaginal and urinary symptoms that many women experience in midlife and afterwards. The new term helps healthcare providers and women themselves take these issues seriously. It also underscores that these changes are not simply a “part of getting older” to be silently endured, but rather a medical condition that can be managed and treated.
A Real-Life Example: Lisa’s Story
Consider the story of Lisa (not her real name), a 51-year-old patient who visited her primary care provider for what she believed was an unusual urinary tract infection. She rarely had UTIs in the past. When she brought this up, she was told that more frequent UTIs were a normal result of aging. This dismissal left her confused and discouraged. She sensed something more was going on and sought another opinion.
This is when Lisa booked an appointment with Dr. Bonza at Bonza Health. We recognized Lisa’s symptoms were recognized as part of GSM. It became clear that the natural decrease in her estrogen levels was affecting her vaginal mucosa integrity and contributing to urinary tract infections. Not only did she have the typical burning discomfort of a UTI, but she also noticed increased urinary urgency at night and mild dryness. Once GSM was identified, her treatment plan involved vaginal estrogen. Lisa has had no further UTIs and found a noticeable improvement in everyday comfort after starting therapy.
This story is a reminder that women’s concerns deserve thoughtful investigation. There are meaningful steps that can be taken to ease symptoms, decrease urinary infections, and restore a sense of normalcy.
Why Vaginal Estrogen?
Vaginal estrogen to treat Genitourinary Syndrome of Menopause
According to multiple studies, local estrogen therapy can revitalize tissues by encouraging cell growth and promoting a healthier vaginal environment. The result is thicker, more elastic tissue that resists irritation and infection. A well-known study in the New England Journal of Medicine by Raz and Stamm (1993) demonstrated that postmenopausal women with recurrent UTIs who used intravaginal estrogen had fewer infections compared to those who did not receive estrogen therapy (PubMed ID:8232136). Other research supports local estrogen’s effects in reducing urinary symptoms and improving vaginal health (Kingsberg et al., Journal of Sexual Medicine, 2013, PubMed ID:23679049).
Estrogen therapy prescribed specifically for local use differs from oral hormone therapy. Vaginal creams, tablets, and rings allow a lower dose to be used directly where it’s needed, which reduces the overall systemic absorption. Because the dose is localized, many women who are cautious about oral hormone therapy find vaginal estrogen more acceptable. Importantly, for women who have specific health factors or concerns about oral hormone treatment, talking with a trusted healthcare provider is crucial. Together, you can weigh the pros and cons and choose the best option for your personal situation.
Benefits of Vaginal Estrogen
Vaginal estrogen in Genitourinary Syndrome of Menopause
Improved Vaginal Comfort
Vaginal estrogen replaces the estrogen missing in the local tissues, restoring moisture and elasticity. This eases dryness, itching, and painful intimacy, allowing women to regain comfort in everyday life.Prevention of Urinary Tract Infections
As in Lisa’s situation, recurrent UTIs can be a distressing part of midlife changes. Research demonstrates that restoring local estrogen makes it harder for bacteria to take hold, lowering the likelihood of infections. Women often report fewer UTIs once treatment is started.Lower Urinary Frequency and Urgency
Thinned tissues can contribute to bladder irritation, leading to frequent urges to urinate. Local estrogen often calms these issues, helping women sleep better and feel more at ease in social or work settings.Minimal Systemic Effects
Compared to oral estrogen, local application generally keeps estrogen levels within or near the typical postmenopausal range. This targeted approach can be reassuring for women with concerns about overall hormone exposure. Though side effects are rare, ongoing discussions with a healthcare provider can address any questions or worries.Enhanced Quality of Life
Discomfort in the vaginal and urinary areas affects emotional well-being and can lead to avoiding intimacy or social interactions. By restoring comfort, self-confidence often improves, allowing women to feel more like themselves again.
Addressing Common Concerns
Safety Profile: Many large-scale reviews have demonstrated that low-dose local estrogen is well tolerated. For women with a history of certain cancers or those on specific medications, it is essential to consult a specialist who is familiar with menopausal hormone therapy and its nuances. Each individual’s medical situation deserves personalized advice.
Time to Notice Changes: Some benefits can appear in just a few weeks, but it’s not unusual for full effects to take a few months. Consistency is important. If you have concerns or don’t see improvement, your doctor can adjust the dose or form of therapy.
Possible Side Effects: Mild irritation or spotting can happen when first starting therapy, but these issues often resolve with time. If you experience persistent problems, let your healthcare team know.
Long-Term Use: Because GSM persists unless estrogen is replenished, many women continue therapy indefinitely. There is no definitive “end date” as long as benefits continue and risks remain minimal. Regular check-ins with a provider can ensure you remain on the best treatment plan.
Compassionate and Practical Support
Managing GSM goes beyond a single prescription. A balanced lifestyle can complement therapy and help you feel at your best:
Stay hydrated during perimenopause and menopause
Stay Hydrated: Drinking enough water helps maintain overall urinary health and can ease some urinary irritations.
Choose Appropriate Cleansers: Scented soaps or strong detergents can further irritate sensitive tissues. Opt for gentle, fragrance-free products when caring for intimate areas.
Preventive Measures for UTIs: Urinating after sexual activity and wiping from front to back can reduce the chances of bacterial spread.
Speak with Your Healthcare Provider: If you notice changing symptoms or new concerns, don’t hesitate to seek advice. Ongoing communication can keep your plan effective.
Foster Emotional Well-Being: Symptoms such as dryness, discomfort, or urinary issues can take a toll emotionally, leading to self-consciousness or worry. Sharing these feelings with supportive friends, loved ones, or a counselor can provide relief. Many women find that honest conversations help them feel less alone.
Above all, know that you deserve compassion and understanding. Concerns about intimacy, urinary health, or self-confidence are not trivial. Recognizing the real effect of GSM empowers you to ask for the care you deserve.
Why Awareness Matters
GSM often remains undiscussed, in part because our culture has a tendency to overlook women’s intimate health or chalk problems up to “being older.” This can lead to women feeling as though their experiences are inevitable or unimportant. The reality is that effective treatments exist. Vaginal estrogen, particularly, can be the key to easing these uncomfortable symptoms and breaking the cycle of UTIs.
By shedding light on GSM, we encourage more open communication between women and their healthcare providers. Recognizing that you are not alone can help reduce any sense of isolation or embarrassment. If you suspect you might be dealing with these symptoms, consider speaking with a physician or a gynecologist who understands GSM. You deserve information that’s thorough, compassionate, and tailored to your stage of life.
Moving Forward with Confidence
As a physician working with women every day, I’ve seen how vaginal estrogen can address the discomfort of GSM. By restoring local hormone levels, it helps guard against recurrent UTIs, eases dryness, and improves overall well-being. The Menopause Society underscores the importance of recognizing GSM as part of women’s health that merits attention and proper treatment.
If you or someone you know experiences burning, dryness, recurring UTIs, or urinary urgency during or after menopause, please remember that these issues are common—but they are not something you must simply put up with. Effective solutions exist, and by seeking care, you can gain relief and peace of mind.
Sign up for Fullscript to shop professional-grade perimenopause supplements.
References
Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329(11):753-756. (PMID:8232136)
Kingsberg SA, et al. Vulvar and Vaginal Atrophy in Postmenopausal Women: Findings from the REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal ChangEs) Survey. J Sex Med. 2013;10(7):1790-1799. (PMID:23679049)
The North American Menopause Society.www.menopause.org
